SCHEMBL4960140

SCHEMBL4960140

NC(=O)c1ccsc1-c1ccc2cc(-c3ccc4cc[nH]c4c3)ccc2c1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PI4K2A Q9BTU6 2/20 0.46
▸ IKBKB O14920 9/20 0.44
▸ CHUK O15111 8/20 0.44
▸ RIPK2 O43353 1/20 0.44
▸ LCK P06239 1/20 0.41
▸ BTK Q06187 1/20 0.41
▸ CHEK1 O14757 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ENPP2 Q13822 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ PDPK1 O15530 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.39
▸ ABL1 P00519 1/20 0.38
▸ HSD17B1 P14061 1/20 0.38
▸ HSD17B2 P37059 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4965915 0.77 GSK3B (0.47) RIPK2LCKBTKCHEK1KDM4E
SCHEMBL29018616 0.73 HDAC6 (0.39) PI4K2AIKBKBCHUKCHEK1ALDH1A1
SCHEMBL27682000 0.72 LCK (0.56) PI4K2AIKBKBCHUKRIPK2LCK
SCHEMBL28136345 0.72 LCK (0.56) PI4K2AIKBKBCHUKRIPK2LCK
SCHEMBL30369932 0.72 LCK (0.56) PI4K2AIKBKBCHUKRIPK2LCK
SCHEMBL2564058 0.72 ROCK2 (0.50) RIPK2LCKBTKCHEK1KDM4E
SCHEMBL3663816 0.72 CCNT1 (0.58) PI4K2AIKBKBCHUKRIPK2LCK
SCHEMBL1828299 0.70 PI4K2A (0.50) PI4K2AIKBKBCHUKRIPK2LCK
SCHEMBL15775800 0.70 ACMSD (0.46) LCKKDM4E
SCHEMBL29437284 0.69 PI4K2A (0.55) PI4K2AIKBKBCHUKRIPK2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896461-A2 BIS-ARYL KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF INFLAMMATION, ANGIOGENESIS AND CANCER Amgen Inc. (US) 2008-03-12 — — EP disclosed
WO-2007005668-A2 BIS-ARYL KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF INFLAMMATION, ANGIOGENESIS AND CANCER AMGEN INC. (US) 2007-01-11 — — WO disclosed
Send feedback